Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Jul 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Aug 06, 2024
LDC Adopt Process Lead - Taxes INSURGENTES Mexico Operations CTS Audit & Finance Aug 19, 2024
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance Aug 30, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Buyer LACan (Temporary) INSURGENTES Mexico Operations CTS Procurement Sep 15, 2024
Project Controller INSURGENTES Mexico Operations Innovative Medicines Technical Operations Aug 13, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
SCM specialist INSURGENTES Mexico Operations Innovative Medicines Technical Operations Oct 07, 2024
Good Clinical Practices and Pharmacovigilance Sr. Auditor INSURGENTES Mexico Operations Innovative Medicines Quality Oct 11, 2024
Sales Value Manager Speciality Care INSURGENTES Mexico International Innovative Medicines Sales Oct 11, 2024
RLT Customer Support INSURGENTES Mexico US Innovative Medicines Technical Operations Oct 10, 2024
Digital Quality Control specialist INSURGENTES Mexico Operations Innovative Medicines Quality Oct 17, 2024
Quality Business Excellence Coordinator INSURGENTES Mexico Operations Innovative Medicines Quality Oct 18, 2024
SSU Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 15, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 21, 2024
Sales Value Associate Oncologia&Hematologia INSURGENTES Mexico International Innovative Medicines Sales Sep 25, 2024
Specialist - Quality Operations (APQR) INSURGENTES Mexico Operations Innovative Medicines Quality Sep 27, 2024
Quality Operations Specialist - Batch Release INSURGENTES Mexico Operations Innovative Medicines Quality Oct 07, 2024
Sales Value Associate - Monterrey Público INSURGENTES Mexico International Innovative Medicines Sales Oct 11, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 16, 2024
Oncology MSL INSURGENTES Mexico International Innovative Medicines Research & Development Oct 18, 2024
Customer Experience and Omnichannel Manager INSURGENTES Mexico International Innovative Medicines Marketing Oct 18, 2024
Patient Journey Partner Lead GTx INSURGENTES Mexico International Innovative Medicines Research & Development Oct 21, 2024
Intake Specialist INSURGENTES Mexico US Innovative Medicines Facilities & Administration Sep 02, 2024
QA Specialist APQR INSURGENTES Mexico Operations Innovative Medicines Quality Sep 03, 2024
Sales Value Associate Privado - Guadalajara INSURGENTES Mexico International Innovative Medicines Sales Oct 09, 2024
Sales Value Associate CDMX - Privado INSURGENTES Mexico International Innovative Medicines Sales Aug 01, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
Sales Value Associate CDMX (Virtual) INSURGENTES Mexico International Innovative Medicines Sales Sep 13, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia